-Hi-Tech Pharmacal Announces Final Approval and 180 Day Market Exclusivity Receipt for Gabapentin Oral Solution

M2 EquityBites › February 23, 2011

Linked as:

Summary

M2 EQUITYBITES-February 23, 2011-Hi-Tech Pharmacal announces final approval and 180 day market exclusivity receipt for gabapentin oral solution

(C)1994-2011 M2 COMMUNICATIONS http://www.m2.com

See the full content of this document

Extract

-Hi-Tech Pharmacal Announces Final Approval and 180 Day Market Exclusivity Receipt for Gabapentin Oral Solution

Specialty pharmaceutical company Hi-Tech...

See the full content of this document

Sponsored links

ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Language

Contents in vLex United Kingdom

Explore vLex

For Professionals

For Partners

Company

Other documents:

-danish dsv's pre-tax profit tops analyst estimates in q3 2011 | city shops scrutinised by experts | pini jumps to chelsea tune | getting their hands dirty penyrheol [...] | Floyd Fuel Co. 453 1960 | Patrick v Great Valley Sch 3rd Cir 2008 | us v ward 4th cir 2009 | easyQual.com Announces Partnership With MBNA Corporation To Market Loan Products.